Physiomics (LON:PYC) Stock Price Up 4.1% – Still a Buy?

Physiomics Plc (LON:PYC)’s stock price rose 4.1% on Thursday . The company traded as high as GBX 0.78 ($0.01) and last traded at GBX 0.78 ($0.01). Approximately 1,979,196 shares traded hands during mid-day trading, an increase of 16% from the average daily volume of 1,709,716 shares. The stock had previously closed at GBX 0.75 ($0.01).

Physiomics Stock Up 4.9 %

The firm has a market cap of £1.65 million, a PE ratio of -13.83 and a beta of 1.69. The firm’s 50 day moving average is GBX 0.69 and its 200-day moving average is GBX 0.75.

Insider Buying and Selling

In related news, insider Peter Sargent acquired 459,090 shares of the company’s stock in a transaction dated Thursday, November 7th. The shares were bought at an average cost of GBX 1 ($0.01) per share, with a total value of £4,590.90 ($5,776.90). 4.18% of the stock is currently owned by corporate insiders.

Physiomics Company Profile

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software.